Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2000
12/14/2000WO2000075376A1 Hepg2 cells stably transfected with hcv
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075372A1 A process for preparing peptide nucleic acid probe using polymeric photoacid generator
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075364A2 Nmr rapid identification of bi-ligand drug candidates
12/14/2000WO2000075363A2 Enzymatic measurement of mycophenolic acid
12/14/2000WO2000075361A2 Method to determine the toxicity caused by exposure to chemical and physical agents
12/14/2000WO2000075360A2 Method and apparatus for enzyme detection
12/14/2000WO2000075339A1 Substrate trapping protein tyrosine phosphatases
12/14/2000WO2000075334A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000WO2000075333A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000WO2000075332A2 USE OF THE REGULATORY SUBUNIT OF THE CAMP DEPENDENT PROTEIN KINASE (PKA) FROM DICTYOSTELIUM FOR cAMP MEASUREMENTS
12/14/2000WO2000075328A1 Human sel-10 polypeptides and polynucleotides that encode them
12/14/2000WO2000075322A1 Insect monoamine transporter and methods of use thereof
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075317A2 Compositions and methods for the treatment of tumor
12/14/2000WO2000075313A1 Method for judging rheumatoid arthritis
12/14/2000WO2000075311A1 Recombinant nematode nicotinic receptor and uses
12/14/2000WO2000075309A1 Spliceosome protein and its use
12/14/2000WO2000075305A2 Candida albicans genes and proteins coded by said genes
12/14/2000WO2000075278A2 Gene encoding nade, p75ntr-associated cell death executor and uses thereof
12/14/2000WO2000075237A2 pH SENSITIVE CYANINE DYES AS REACTIVE FLUORESCENT REAGENTS
12/14/2000WO2000075214A1 Method of partitioning blood using polyesters
12/14/2000WO2000075190A2 Hybridomas for lung cancer marker and monoclonal antibodies thereof
12/14/2000WO2000075179A1 Chromatographic determination of p-glycoprotein reactive ligands
12/14/2000WO2000075169A1 Novel fabh enzyme, compositions capable of binding to said enzyme and methods of use thereof
12/14/2000WO2000075167A2 Phosphorylation assays
12/14/2000WO2000075166A1 Melanin concentrating hormone receptor
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075160A1 Assays for apoptosis modulators
12/14/2000WO2000074850A2 Microfluidic devices for transverse electrophoresis and isoelectric focusing
12/14/2000WO2000074725A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000WO2000074717A1 NOVEL Ig FRACTIONS HAVING AN IMMUNOMODULATORY ACTIVITY
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074705A1 Rheumatic autoimmune disease antigen
12/14/2000WO2000074686A1 Modulators of methylation for control of bacterial virulence
12/14/2000WO2000074671A1 Method and markers for prognosticating efficacy of anticancer agents
12/14/2000WO2000074667A2 Compositions active in telomere damage comprising a taxane and telomerase inhibitor
12/14/2000WO2000074662A2 Arthritis treatment
12/14/2000WO2000074553A2 Gas analyzer calibration checking device
12/14/2000WO2000063419B1 Combinatorial chemical library supports having indicia at coding positions and methods of use
12/14/2000WO2000057190A3 Prediction of diabetes impaired wound healing
12/14/2000WO2000055355A3 Method of screening candidate compounds for susceptibility to biliary excretion
12/14/2000WO2000054049A3 Determination of the chemosensitivity via the caspase activity
12/14/2000WO2000053776A3 Human kallikrein-like genes
12/14/2000WO2000053640B1 Controlled free radical emulsion and water-based polymerizations and seeded methodologies
12/14/2000WO2000050902A3 High throughput assay based on the use of a polypeptide binding pair
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000049409A3 ASSAY FOR THE IDENTIFICATION OF IgE ANTIBODY SUPPRESSORS
12/14/2000WO2000049178A3 Polynucleotide sequencing method
12/14/2000WO2000049039A3 Glucose dehydrogenase fusion proteins and their utilization in expression systems
12/14/2000WO2000047612A3 Structure-based screening techniques for drug discovery
12/14/2000WO2000047231A3 Novel antisense inhibition of rad51
12/14/2000WO2000046593A3 A micro-electronic bond degradation sensor and method of manufacture
12/14/2000WO2000046236A3 Novel rgs-containing molecules and uses thereof
12/14/2000WO2000045163A3 Microsensor housing
12/14/2000WO2000043498A3 Human liver progenitors
12/14/2000WO2000033872A9 Method of and compositions for immunization with the pseudomonas v antigen
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000DE19926728A1 Deformable, hardenable or film-forming carrier containing intraoral diagnostic additives, useful for the simultaneous detection of multiple oral conditions
12/14/2000DE19926680A1 Testing head for producing material-specific emissions for testing and calibrating monitoring devices has a support on which elements, compounds, mixtures or other technical chemical formulation are applied
12/14/2000DE19926541C1 Fine air feed to natural gas by peristaltic micro-pump prevents irreversible change to odor measuring cells
12/14/2000DE19926475A1 Träger-Pharmaka-Konjugate Carrier conjugates drugs
12/14/2000DE19926139A1 Kalibrierung eines NOx-Sensors Calibration of a NOx sensor
12/14/2000DE19925402A1 Screening von Target-Ligand-Wechselwirkungen Screening of target-ligand interactions
12/14/2000DE19925234A1 Capsomere, stabile Capsomere, Capside, VLPs, oder CVLPs bzw. damit beladenen Zellen und ihre Verwendung in Diagnostik und Therapie Capsomeres, stable capsomeres, capsids, VLPs, or CVLPs or so loaded cells and their use in diagnosis and therapy
12/14/2000DE19920580C1 Process and assembly determine total organic carbon content within liquid sample using larger sample to enhance accuracy
12/14/2000DE19920233A1 Determining dialysis urgency and treatment plan for kidney disease, is achieved by gas analysis of respired air and body fluids, measuring variance from normal state followed by data processing in adaptive model
12/14/2000DE10023923A1 Verfahren zur Bestimmung der Aktivität der Faktor VII-aktivierenden Protease aus Proteinlösungen A method for determining the activity of the factor VII-activating protease from protein solutions
12/14/2000CA2504679A1 Compositions and methods for the treatment of tumor
12/14/2000CA2501815A1 Compositions and methods for the treatment of tumor
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2376825A1 Chromatographic determination of p-glycoprotein reactive ligands
12/14/2000CA2376642A1 Recombinant nematode nicotinic receptor and uses
12/14/2000CA2376438A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000CA2376400A1 Compounds and methods to enhance raav transduction
12/14/2000CA2376335A1 Novel ig fractions having an immunomodulatory activity
12/14/2000CA2376314A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376192A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000CA2376058A1 Use of the regulatory subunit of the camp dependent protein kinase (pka) from dictyostelium for camp measurements
12/14/2000CA2376055A1 Spliceosomal protein and its use
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2375861A1 Method and markers for prognosticating efficacy of anticancer agents
12/14/2000CA2375740A1 Ph sensitive cyanine dyes as reactive fluorescent reagents
12/14/2000CA2375708A1 Assays for apoptosis modulators
12/14/2000CA2375456A1 Methods and compositions for assuring reduction of nox emissions from an engine by selective catalytic reduction
12/14/2000CA2375447A1 A method of determining potential susceptibility to development of alte and/or sids
12/14/2000CA2375446A1 Mastitis detection method
12/14/2000CA2375145A1 Substrate trapping protein tyrosine phosphatases
12/14/2000CA2374587A1 Hybridomas for lung cancer marker and monoclonal antibodies thereof
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2373356A1 Detection of ryanodine receptor antibodies
12/14/2000CA2373340A1 Nmr-solve method for rapid identification of bi-ligand drug candidates
12/14/2000CA2373069A1 Assay for detecting the enzymatic activity of a phosphorylation enzyme using enhanced signal generation
12/14/2000CA2371434A1 Compositions and methods for the treatment of tumor
12/14/2000CA2339255A1 Hepg2 cells stably transfected with hcv
12/13/2000EP1059534A2 Simultaneous determination of forward and reverse ABO blood group
12/13/2000EP1059533A1 Method for immunochemically assaying anti-hm1.24 antibody
12/13/2000EP1059532A2 Urine cancer test
1 ... 3043 3044 3045 3046 3047 3048 3049 3050 3051 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 ... 3937